Jones Lang LaSalle


Franklin Credit Management CEO Walks

Franklin Credit Management today announced that Jeffrey Johnson has resigned as president and CEO. He has also stepped down from the company's board of directors.
Johnson joined the specialty consumer-finance company, which has offices in Jersey City, 15 months ago. Effective immediately, Thomas Axon, founder and chairman, has been appointed president and CEO. - Martin C. Daks

BMO Financial to Launch Firm in Jersey City

BMO Financial Group, and investment professionals Flavio Bartmann and Conrad Voldstad have invested $50 million to launch Pallium Investment Management in Jersey City's Harborside Financial Center.

The company, which will formally open its doors around the third quarter, will be primarily focused on credit derivatives and has plans to develop other product lines. Pallium is currently recruiting portfolio and credit managers. - Martin C. Daks

Sapphire Adds New Director

Sapphire Therapeutics today announced it has added a new director and appointed a scientific advisory board. The Bridgewater-based biopharmaceutical company has named Herbert J. Conrad as its sixth director.

Conrad’s experience includes serving as the U.S. president of Roche Pharmaceuticals. He currently sits on the boards of Savient Pharmaceuticals, Celldex Therapeutics and Symphony Evolution.

Sapphire also announced the appointment of nine medical and pharmacology professionals to the company's first scientific advisory board. Sapphire, a biopharmaceutical company, licenses and develops small-molecule drug candidates to treat metabolic and oncologic diseases. - Martin C. Daks